A Non-Interventional Trial of Xeloda in Metastatic Colorectal Cancer, Adjuvant Colon Cancer, Advanced Gastric Cancer and Breast Cancer
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Breast Cancer, Gastric Cancer, Colorectal Cancer
Both
Breast Cancer, Gastric Cancer, Colorectal Cancer
Trial Information
A Non-Interventional Trial of Xeloda in Metastatic Colorectal Cancer, Adjuvant Colon Cancer, Advanced Gastric Cancer and Breast Cancer
Inclusion Criteria:
- Patients with metastatic colorectal cancer, colon cancer in the adjuvant setting,
advanced gastric cancer or breast cancer who are candidates for receiving Xeloda
according to product label
Exclusion Criteria:
- Contraindications according to label and off-label use
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Number of treatment cycles in routine clinical practice
Outcome Time Frame:
approximately 2 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Austria: Ethikkommission
Study ID:
ML25281
NCT ID:
NCT01664494
Start Date:
April 2010
Completion Date:
July 2012
Related Keywords:
- Breast Cancer, Gastric Cancer, Colorectal Cancer
- Breast Neoplasms
- Colonic Neoplasms
- Colorectal Neoplasms
- Stomach Neoplasms
Name | Location |
|---|
